Safety Trial of STING-dependent Activators and Stimulated Dendritic Cells for Aggressive Relapsed/Refractory Leukemias

NCT05321940 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Investigator decision

Conditions

Refractory Leukemia
Relapsed Leukemia
Acute Myelogenous Leukemia
Acute Lymphoblastic Leukemia
Adult T-Cell Leukemia/Lymphoma

Interventions

BIOLOGICAL: STING-Dependent Activators (STAVs) Loaded Autologous Leukemic Cells
BIOLOGICAL: Dendritic Cell Vaccine

Sponsor

Juan C. Ramos, MD